✦ LIBER ✦

Epidermal growth factor receptor gene copy number in 101 advanced colorectal cancer patients treated with chemotherapy plus cetuximab

✍ Scribed by Carla Campanella; Marcella Mottolese; Anna Cianciulli; Angela Torsello; Roberta Merola; Isabella Sperduti; Elisa Melucci; Salvatore Conti; Maria Grazia Diodoro; Massimo Zeuli; Giancarlo Paoletti; Francesco Cognetti; Carlo Garufi

Book ID: 119905615
Publisher: BioMed Central
Year: 2010
Tongue: English
Weight: 456 KB
Volume: 8
Category: Article
ISSN: 1479-5876
DOI: 10.1186/1479-5876-8-36

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epidermal growth factor receptor (EGFR)

Epidermal growth factor receptor (EGFR) gene promoter methylation and cetuximab treatment in colorectal cancer patients

✍ Scartozzi, M; Bearzi, I; Mandolesi, A; Giampieri, R; Faloppi, L; Galizia, E; Lou 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 248 KB

Epidermal growth factor receptor R521K p

Epidermal growth factor receptor R521K polymorphism shows favorable outcomes in KRAS wild-type colorectal cancer patients treated with cetuximab-based chemotherapy

✍ Yao-Yu Hsieh; Cheng-Hwai Tzeng; Ming-Huang Chen; Po-Min Chen; Wei-Shu Wang 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 306 KB

Epidermal growth factor receptor intron

Epidermal growth factor receptor intron 1 CA dinucleotide repeat polymorphism and survival of advanced gastric cancer patients treated with cetuximab plus modified FOLFOX6

✍ Sae-Won Han; Do-Youn Oh; Seock-Ah Im; Sook Ryun Park; Keun-Wook Lee; Hong Suk So 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

Biweekly cetuximab plus irinotecan as se

Biweekly cetuximab plus irinotecan as second-line chemotherapy for patients with irinotecan-refractory andKRASwild-type metastatic colorectal cancer according to epidermal growth factor receptor expression status

✍ Myoung Joo Kang, Yong Sang Hong, Kyu-pyo Kim, Sun Young Kim, Ji Yeon Baek, Min-H 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 166 KB

Phase II Trial of Cetuximab in Patients

Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor Receptor

✍ Saltz, L. B. 📂 Article 📅 2004 🏛 American Society of Clinical Oncology 🌐 English ⚖ 107 KB

Efficacy of Cetuximab After Treatment wi

Efficacy of Cetuximab After Treatment with Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor—Based Chemotherapy in Metastatic Colorectal Cancer

✍ Jeffrey A. Meyerhardt; Denise Heseltine; Shuji Ogino; Jeffrey W. Clark; Peter C. 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 147 KB